| BRCA2 |
gene |
16 |
3 |
BRCA216 |
| BrdU |
drug |
6 |
4 |
5 μM BrdU, 5-bromo-2'-deoxyuridine, BrdU slow-release pellet, BrdU+, BrdU-IR, bromodeoxyuridine |
| breast cancer |
phenotype |
40 |
15 |
BC, BRCA1-associated breast cancer, BRCA2-associated breast cancer, breast, breast cancer, breast cancer cells, breast cancer risk, breast cancer susceptibility, breast cancers, breast carcinoma, invasive breast cancer |
| breast cancer risk |
phenotype |
2 |
2 |
breast cancer |
| Breath alcohol concentration |
phenotype |
2 |
2 |
BrAC, breath alcohol, breath alcohol levels |
| Breath alcohol level |
phenotype |
4 |
2 |
BAC, breath alcohol, breath alcohol concentration, breath alcohol levels |
| Brevital |
drug |
2 |
1 |
methohexital sodium |
| BRG1 |
gene |
4 |
2 |
Brg1, SMARCA4 |
| Brisbane Longitudinal Twin Study |
cohort |
2 |
2 |
BLTS |
| British Isles |
cohort |
2 |
1 |
|
| Brn2 |
gene |
2 |
1 |
POU3F2 |
| broad depression |
phenotype |
2 |
1 |
depression |
| bronchitis |
phenotype |
2 |
1 |
|
| brown adipose tissue |
phenotype |
2 |
2 |
BAT |
| brown module |
cohort |
2 |
1 |
|
| Bruker mass spectrometry workstation |
drug |
2 |
— |
Bruker |
| BSA |
drug |
25 |
9 |
1% BSA, A2153, Bovine Serum Albumin, Bovine serum albumin, bovine serum albumin, fatty-acid free bovine serum albumin |
| BTBD3 |
gene |
2 |
1 |
BTB/POZ domain-containing 3 |
| bulimia nervosa |
phenotype |
8 |
3 |
BN |
| bullying |
phenotype |
4 |
2 |
bullying |
